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Abstract
Background: Many patients with Parkinson’s disease (PD) lead a sedentary lifestyle. Promotion of physical activities
may beneficially affect the clinical presentation of PD, and perhaps even modify the course of PD. However,
because of physical and cognitive impairments, patients with PD require specific support to increase their level of
physical activity.
Methods: We developed the ParkFit Program: a PD-specific and multifaceted behavioral program to promote
physical activity. The emphasis is on creating a behavioral change, using a combination of accepted behavioral
motivation techniques. In addition, we designed a multicentre randomized clinical trial to investigate whether this
ParkFit Program increases physical activity levels over two years in sedentary PD patients. We intended to include
700 sedentary patients. Primary endpoint is the time spent on physical activities per week, which will be measured
every six months using an interview-based 7-day recall.
Results: In total 3453 PD patients were invited to participate. Ultimately, 586 patients - with a mean (SD) age of
64.1 (7.6) years and disease duration of 5.3 (4.5) years - entered the study. Study participants were younger, had a
shorter disease duration and were less sedentary compared with eligible PD patients not willing to participate.
Discussion: The ParkFit trial is expected to yield important new evidence about behavioral interventions to
promote physical activity in sedentary patients with PD. The results of the trial are expected in 2012.
Trial registration: http://clinicaltrials.gov (nr NCT00748488).
Background
Parkinson’s disease (PD) is a progressive neurological
disorder characterized by both motor symptoms (such
as bradykinesia and postural instability) and non-motor
symptoms (such as depression and cognitive impair-
ment)[1]. Both motor and non-motor symptoms can
result in reduced physical activity[2,3].
Observations in non-parkinsonian populations suggest
that participating in regular physical activity has preven-
tive effects (e.g. cardiovascular events, diabetes mellitus,
dementia)[4-6] and positive symptomatic effects (on
depression[7], sleep disturbances[8], health-related qual-
ity of life)[9]. Studies in PD patients concluded that
brief physical therapy interventions can improve flexibil-
ity, balance and muscle strength[10,11]. In addition, pre-
clinical evidence in animals with experimental
parkinsonism raised the possibility that physical activity
may directly alter the neurodegenerative process[12,13].
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stimulated best to achieve an enduring increase in their
physical activities in daily life, in order to prevent co-
morbid complications and to improve symptoms.
Simply informing subjects about the health benefits of
physical activity is not enough to attain a sustained
behavioral change. The challenges to induce a lasting
change in exercise behavior are particularly great for
neurological patients. To change lifestyle, behavioral
programs should focus on appropriate supervision,
social support from spouses and caregivers, and the
individual’s preferences and needs[14-16]. Achieving an
enduring behavioral change also calls for specific strate-
gies such as goal setting, problem-solving techniques
and motivational interviewing[14,16,17]. Physical activity
promoting programs including such elements were
effective in sedentary people[15], patients with chronic
heart failure[16], and patients with COPD[18].
Stimulated by these observations, we developed the
ParkFit program: a multifaceted intervention to promote
physical activity in sedentary patients with PD. In addi-
tion, we developed the ParkFit trial to investigate
whether this program affords increased physical activity
levels that persist for two years. The trial will also search
for possible health benefits and risks of increased physi-
cal activity. Here, we describe the study design and
baseline characteristics of this ParkFit trial.
Methods
Study Design
The ParkFit trial is a multicentre, randomized controlled
trial comparing two arms: physical therapy with specific
emphasis on promoting a physically active lifestyle (Park-
Fit Program); and matched physical therapy with specific
emphasis on safety and quality of performing daily activ-
ities (ParkSafe Program) (Figure 1). Trial duration is two
years. Full ethical approval has been granted for the
study (CMO Regio Arnhem-Nijmegen). The study is
registered at clinicaltrials.gov (nr NCT00748488).
Patients
We started with all patients who visited their neurolo-
gist in 2007, 2008 or 2009 in 32 participating commu-
nity hospitals. Eligibility criteria were: (a) PD, according
to the UK Brain Bank Criteria[19]; (b) age between 40
and 75 years; (c) sedentary lifestyle defined as: < 3 times
a week vigorous-intensity physical activity for < 60 min-
utes; or < 3 times a week moderate-intensity physical
activity for < 150 minutes);[20] (d) Hoehn and Yahr ≤ 3.
Exclusion criteria were: (a) unclear diagnosis (no gratify-
ing and sustained response to dopaminergic therapy);
(b) MMSE < 24); (c) unable to complete Dutch ques-
tionnaires; (d) severe co-morbidity interfering with daily
functioning; (e) daily institutionalized care; and (f) deep
brain surgery. Informed consent was obtained before the
first assessment.
The Intervention
After baseline assessment, patients were randomly
assigned to the ParkFit or ParkSafe Program. In both
groups, patients receive high quality physical therapy:
both interventions are delivered exclusively by experi-
enced therapists who participate in the Dutch Parkin-
sonNet[21,22]. Patients in both treatment arms are
offered an equal maximum number of treatment ses-
sions (i.e. 35 sessions of 30 minutes a year; Table 1).
Therapists contact patients at least every six months to
investigate if there are new aims.
ParkFit Program
Widely used behavioral change techniques, with demon-
strated effectiveness[16,18] and based on models of
behavioral change[14,17], are combined in the ParkFit
Program to stimulate patients to increase their physical
activity levels.
1) Brochure ParkFit Patients receive a brochure cover-
ing specific strategies to promote a behavioral change.
These strategies include: education about the benefits of
physical activity, advice about suitable activities, identify-
ing and overcoming any perceived barriers to engage in
physical activity, setting goals, and recruiting social sup-
port[14,23,24]. Part of the educational workbook is a
health contract: a written agreement signed by the
patient and physiotherapist to support them in initiating
and maintaining physical activities[25]. A logbook moni-
tors the specific goals.
2) Personal Activity Coach Physical therapists serve as
personal activity coaches who guide patients towards a
Figure 1 Design of the ParkFit study.
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Their task is to educate patients about the beneficial
effects of physical activity. Patients are additionally sti-
mulated to participate in group exercise to experience
the beneficial effects of physical activity and to receive
social support from fellow patients[26]. For safety rea-
sons, all patients are encouraged to receive a preventive
sports medical screening.
3) Goal setting Patient and coach create activity goals
in order to obtain the 6-month-goals (as formulated in
the health contract). Goals have to be realistic, concrete
and individualized and have to be formulated in a sys-
tematic way, based on behavioral change theories[25].
4) Ambulatory Activity Monitor with visual feedback
Patients receive a personal ambulatory monitor with
automated visual feedback showing the amount of actu-
ally delivered daily physical activity, recorded by a triax-
ial accelerometer[27,28]. Additionally, a personalized
website shows the activity history[27]. Previous work
showed that feedback from pedometers increases physi-
cal activity levels in COPD patients[29], sedentary work-
ers[30] and patients with diabetes mellitus[31].
Table 1 The ParkFit and the ParkSafe program
ParkFit ParkSafe
Intensity
Year 1
Maximum of 19 physical therapy sessions based on problems and
disabilities as perceived by each individual patient; the systematic
way of
tailoring goals is described in the evidence-based guideline for
physical
therapy in PD
Maximum of 35 physical therapy sessions based on problems
and
disabilities as perceived by each individual patient; the
systematic way
of tailoring goals is described in the evidence-based
guideline
for physical therapy in PD
16 coaching sessions to identify and focus on individual beliefs
and aims to
promote a physically active lifestyle
Intensity
Year 2
Maximum of 23 physical therapy sessions based on problems and
disabilities as perceived by each individual patient
Maximum of 35 physical therapy sessions based on problems
and
disabilities as perceived by each individual patient
12 coaching sessions to identify and focus on individual beliefs
and aims to
promote a physically active lifestyle
Specific
Elements
ParkFit Brochure:
￿ Education about benefits of physical therapy
￿ Identifying aims of physical therapy
￿ Education about the benefits of physical activity
￿ Identifying barriers to engage physical activity
￿ Setting goals
￿ Recruiting social support
￿ Sign a health contract to support patients in initiating and
maintaining
physical activities
￿ A logbook to describe and monitor the specific goals
ParkSafe Brochure:
￿ Education about benefits of physical therapy
￿ Identifying aims of physical therapy
￿ Education about the importance of safety when performing
daily activities
Physical therapist:
who treat the patient in order to obtain the aims of
the individual projected treatment plan
Personal Activity Coach:
who guide patients towards a more active
lifestyle
Physical therapist:
who treat the patient in order to obtain the aims of
the individual projected treatment plan
Goal setting: creating goals to increase the level
of physical activity in order to obtain the half-
year-goals as formulated in the health contract;
goals will be evaluated as well as experienced
barriers and possible solving techniques
Ambulatory Activity Monitor: gives visual
feedback about the level of physical activity
during the day
Bi-annual newsletter: specific information about
physical activity, general information about
Parkinson’s disease, and general entertainment in
order to facilitate compliance
Bi-annual newsletter: specific information about
physical therapy, general information about
Parkinson’s disease, and general entertainment in
order to facilitate compliance
van Nimwegen et al. BMC Neurology 2010, 10:70
http://www.biomedcentral.com/1471-2377/10/70
Page 3 of 95) Physical therapy The ParkFit Program also includes
a maximum of 19 physical therapy sessions in year 1
and 23 in year 2. Based on individual disabilities, thera-
pist and patient jointly formulate treatment aims based
on the evidence-based guideline of physical therapy for
PD[32].
ParkSafe Program
The ParkSafe Program includes physical therapy inter-
ventions from the physical therapy guideline for PD[32]
to stimulate patients to move more safely, e.g. by
improving the quality of transfers, but without explicit
emphasis on reaching a physically active lifestyle.
1) Brochure ParkSafe Patients receive a brochure with
information about the benefits of physical therapy[32].
Specific emphasis is given to the importance of safety
when performing daily activities.
2) Physical therapy Patients receive an individualized
physical therapy program. We maximized the total
number of sessions at 35/year, to avoid large differences
in number of treatment sessions between the two arms
(patients in the ParkFit arm also receive 35 annual ses-
sions: 19 physiotherapy plus 16 coach sessions). 35 ses-
sions is considered sufficient for patients in Hoehn and
Yahr stage ≤ 3. Physical therapist and patient jointly for-
mulate the aims of the projected treatment plan, based
on individual problems and disabilities. The aims of the
physical therapy sessions in both treatment arms are
derived from the guideline for physical therapy in PD.
Implementation
Training for physical therapists
All participating physical therapists were specifically
trained to treat patients in both treatment arms and
informed about the aim of the study. Special attention
was given to models of behavioral change,[14,17] to spe-
cific strategies of coaching sedentary patients,[15,33] and
to the technique of setting realistic, concrete and indivi-
dualized goals[25]. Throughout the trial, therapists con-
tinuously register the individual treatment sessions.
Outcome measures
Baseline characteristics
Blood pressure, height, body weight, education and
employment are assessed at baseline as well as alcohol
use, smoking history and lifetime physical activity[34].
Participants in the ParkFit Program also completed a
questionnaire about attitude, social support and self-effi-
cacy towards physical activity.
Primary endpoint: level of physical activity
Primary endpoint is the level of physical activity, as
measured with a 7-day recall, based on an interview-
based physical activity questionnaire, the LAPAQ[35].
Patients are asked to list their daily amount of activity
(frequency and duration), so total time spent on physical
activity (in hours per day) will be calculated. A MET-
value will be used to calculate the number of kilocal-
ories spent per day per kilogram of body weight[36].
The LAPAQ is completed during a face-to-face inter-
view (at baseline, 12 and 24 months) and at additional
time points by telephone (6 and 18 months). We assume
that patients will increase their level of physical activity
during the first months of intervention and then main-
tain this level. Therefore, main endpoint is the level of
physical activity during the entire follow-up period (i.e.
the mean of 6, 12, 18 and 24 months).
Secondary endpoints (Table 2)
Secondary measures include: (a) physical fitness, mea-
sured with the six minute walk test (6MWT)[37]; (b)
quality of life, measured with the PDQ-39[38]; and (c)
level of physical activity in time and kilocalories per
week, measured with the same tri-axial accelerometer
that is used as feedback-tool in the ParkFit Program[28].
The level of physical activity is additionally measured
with a physical activity diary.
Additional measures
Patients who increased their amount of physical activity
will be compared with patients unable to achieve this,
to assess specific health consequences. Disease progres-
sion (UPDRS motor section [39]; 9-hole peg board test
[40]), mobility (Timed Up and Go test[41]), quality of
sleep (SCOPA-sleep[42]), anxiety and depression
(HADS[43]), fatigue (Fatigue Severity Scale[44]), and
cognitive functioning (Table 2 for test battery) are
assessed. Additionally, physical fitness is measured with
the Åstrand-Ryhming test[45]. Bone mineral density
(dual energy X-ray absorptiometry, DXA) is determined
in a subgroup of 300 patients. PD medication and medi-
cal costs (combined with the EQ-5D[46]) are assessed,
as well as the number of falls (as an index of safety).
Patients are asked whether their falls occurred during
exercise and about the consequences of falls (e.g.
injuries). Information about other adverse events is
collected systematically at each physical assessment.
Blinding
To avoid bias due to more positive expectations of
patients towards the outcomes of the ParkFit Program,
patients were initially informed about the fact that there
are two intervention groups, each with a beneficial inter-
vention. To ensure blinding during assessments, patients
are assessed by trained assessors who are unaware of
group allocation. Patients are explicitly asked to not
share their experiences with the program during the
assessments.
Sample size calculation
Based on the following power considerations, we aimed
to include a total of 700 patients. In a small observa-
tional study on physical activity in PD, patients scored
45% less on the LAPAQ compared to controls
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110%. Based on a difference of 15% (with coefficient of
variation of 110%) between both treatment arms, the
study will have at least 80% power (when the correlation
between baseline and follow-up measurements is at least
0.50 and when the correlation between the various fol-
low-up measurements is at most 0.85). This is also the
power when the correlations are at least 0.60 and at
most 0.95, respectively. The power is based on two-
sided 95% confidence intervals. We assumed that
patients would take part in exercise groups with on
average eight participants and that the corresponding
ICC would be 0.1. Based on a previous trial of physical
therapy for PD involving the national ParkinsonNet
networks[21], we expect a drop-out rate of 10%.
Randomization
A minimization algorithm is used to randomize patients,
with the factors region, Hoehn & Yahr stage, age,
gender and current level of physical activity.
Statistical analyses
All participants who really started with their program,
will be included in the primary analysis. The results
after 6, 12, 18 and 24 months will be evaluated using a
linear mixed model with random nested factors ‘patient’
and ‘exercise group’. Fixed factors will be treatment
arm, LAPAQ score at baseline, month, month*treatment
(interaction), and the factors region, H&Y stage, age,
gender and bone density assessment. In an additional
analysis, the influence of H&Y stage, age, gender and
level of previous sports activities on the success of the
Table 2 An overview of patient assessments
Baseline 6 months 12 months 18 months 24 months
Visit &
Questionnaires
Questionnaires Visit &
Questionnaires
Questionnaires Visit &
Questionnaires
Physical Activity
LAPAQ xxxxx
Activity Monitor xxxxx
Activity Diary xxxxx
Physical Fitness
6 MWT xxx
Åstrand-Ryhming test xxx
Quality of Life
PDQ-39 xxxxx
Health Effects
UPDRS III, motor function xxx
Nine hole peg board test xxx
Timed up and go test xxx
DXA x
SCOPA-sleep xxxxx
HADS xxxxx
FSS xxxxx
Cognitive testing battery* xxx
PD medication xxxxx
Medical costs & EQ-5D xxxxx
Number of falls (monthly) xxxxx
Determinants
Blood pressure xxx
Height xxx
Body weight xxx
Education x
Employment x
Alcohol use xxx
Smoking xxx
Lifetime physical activity x
Attitude, SS & SE** x
* Including tests for spatial working memory[49], intra- and extra-dimensional shift performance[50,51], paired associate learning performance[50], phonemic and
semantic word fluency[52], and complex figure drawing[53]
** Only patients in the ParkFit Program
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terms between treatment and each of these variables in
the model. Multiple imputation analyses will be used to
evaluate the impact of missing values on the outcome.
Throughout, 95% confidence intervals will be calculated.
Results
Inclusion procedure
Selection of patients ran from September 2008 to Janu-
ary 2010. A total number of 4479 patients received a
screening questionnaire; 587 (13.1%) did not respond,
439 (9.8%) were excluded because there was doubt
about the diagnosis (Figure 2). After invitation for parti-
cipation, 1766 patients were excluded based on our
exclusion criteria, and 1101 eligible patients were
excluded because they were not willing to participate.
Finally, 586 patients signed informed consent. The num-
ber of enrolled patients is less than the power calcula-
tion required. However, the power remains over 80%
because only 60% of patients participates in exercise
groups with an average group size of only three, whereas
our power calculation assumed that all patients would
participate in exercise in groups of eight patients.
Baseline characteristics
The most relevant baseline characteristics of included
patients are presented in Table 3 and compared with
the characteristics of the complete cohort of PD patients
and the cohort of patients who were eligible but not
willing to participate. Study participants were younger,
had a shorter disease duration and were less sedentary
compared with eligible patients not willing to
participate.
Discussion
Several lines of evidence suggest that regular participa-
tion in physical activity could be important for patients
with PD[47]. The ParkFit trial was designed to evaluate
a multifaceted program to achieve an enduring increase
in physical activity in PD patients. The intervention is
b a s e do na c c e p t e dm o t i v a t i o nal and behavioral change
models[14,16,17], which will now be employed for the
first time in PD.
We carefully monitored the characteristics of all
invited patients as well as eligible patients who were not
willing to participate. The results demonstrate that
among all PD patients who were invited, 64% indeed
had a sedentary lifestyle. The results further demon-
strate that eligible PD patients not willing to participate
were on average somewhat more sedentary in compari-
son with the participants of the study. Should our study
shows a beneficial effect of the ParkFit behavioral
change program, efforts must be made to also reach out
to this subgroup of sedentary patients.
A critical issue in rehabilitation studies is the choice
for an appropriate control condition, and we have
selected a program that emphasized safety of movement
(according to evidence-based guidelines[32]), rather than
the quantity of movements. Both intervention programs
are matched for intensity, and are delivered by the same
therapists. We have taken several measures to avoid bias
between both treatment arms, rendering both groups
comparable except for the focus on physical activities.
Because the same therapists participate in both pro-
grams, differences in their personalities should not differ
between the two treatment arms. A possible drawback is
contamination. Furthermore, personal preference for a
specific program can possibly introduce variation
between therapists. We strive to avoid this by: (1)
Figure 2 Flow chart of the inclusion procedure. * No Parkinson’s
disease = patient is diagnosed with parkinsonism or patient declared
to have no gratifying and sustained response to dopaminergic therapy;
** No sedentary lifestyle = > 3 times a week vigorous-intensity physical
activity > 60 minutes; or > 3 times a week moderate-intensity physical
activity > 150 minutes; *** Severe disease = H&Y > III; MMSE < 24;
severe co-morbidity interfering with daily functioning; use of daily care
in an institution; or deep brain stimulation.
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of the study and the do’sa n dd o n ’ts in both treatment
arms. They have signed a contract and agreed to keep
both programs separate. (2) The tools used in ParkFit
are not freely available. Since all patients receive their
own Activity Monitor and brochure, therapists cannot
give these tools to patients allocated to ParkSafe. (3)
During the trial, therapists are being visited and
observed during one or more sessions. A standardized
checklist of prescribed interventions will be completed
to investigate if contamination is at play. (4) Each thera-
pist will be interviewed, between 3 to 6 months after
start of the program. The aim is to investigate how
therapists put the program into practice, and to re-
emphasize the do’sa n dd o n ’ts of both programs. (5)
About every two months, the research team contacts
each therapist to ask them about their individual aims
in both treatment arms. Again, it is emphasized that
coaching towards a more physically active lifestyle is not
allowed in ParkSafe. (6) Yearly, a ‘booster’ session is
planned for therapists to discuss possible problems and
to re-emphasize the do’s and don’ts.
A strong element of the ParkFit trial is the availability
of our national ParkinsonNet networks[21], which
allows us to administer the interventions in both treat-
ment arms by therapists with documented experience in
treating PD patients. The ParkFit trial is one of the lar-
gest and longest lifestyle intervention trials in PD, and is
the first one to focus on behavioral change as an inter-
mediate to achieve a sustained increase in physical activ-
ity levels.
The endpoints of this trial cover several complemen-
tary domains. A prerequisite is that patients will actually
increase their physical activity levels. To document this,
we have selected the time spent on physical activities
per week as primary endpoint. We choose the LAPAQ
as primary outcome measure instead of the Activity
Monitor because a questionnaire covers a wider range
of activities[48].
We also want to see whether physical activity affords
any symptomatic relief of PD. To this end we have
included a battery of additional endpoints (including
quality of life) that measure possible health benefits for
patients. Safety is also an issue, because physical activity
may theoretically predispose patients to falls. Therefore,
this will also be documented in this study. Furthermore,
costs will be recorded, alth o u g hw eh a v en os p e c i f i ca
priori reason to expect drastic increases or reductions in
costs associated with the interventions of this trial.
In conclusion, the ParkFit trial is expected to yield
important new knowledge about behavioral interven-
tions for patients with PD to change their sedentary life-
style. If the ParkFit Program shows good treatment
compliance and beneficial symptomatic effects, future
trials could identify which components of our multifa-
ceted approach are most effective. In addition, positive
results may have implications for different neurological
disorders where beneficial effects of physical activity
may be expected. The results of the ParkFit trial are
scheduled for 2012.
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